| A novel VPS13B mutation in Cohen syndrome: a case report and review of literature S Momtazmanesh, E Rayzan, S Shahkarami, M Rohlfs, C Klein, N Rezaei BMC Medical Genetics 21, 1-6, 2020 | 33 | 2020 |
| microRNA‐related single‐nucleotide polymorphisms and breast cancer F Bahreini, E Rayzan, N Rezaei Journal of Cellular Physiology, 2020 | 28 | 2020 |
| Immunotherapy a new hope for cancer treatment: A review. M Shirkhoda, F Memari, H Dana, H Mahmoodzadeh, N Samarghandi, ... Pakistan journal of biological sciences: PJBS 21 (3), 135-150, 2018 | 28 | 2018 |
| Exosomes derived from mesenchymal stem cells improved function and survival of neutrophils from severe congenital neutropenia patients in vitro M Mahmoudi, M Taghavi-Farahabadi, S Namaki, K Baghaei, E Rayzan, ... Human immunology 80 (12), 990-998, 2019 | 25 | 2019 |
| Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms S Khanmohammadi, M Shabani, M Tabary, E Rayzan, N Rezaei Critical Reviews in Oncology/Hematology 150, 102945, 2020 | 23 | 2020 |
| The significant coronary tortuosity and atherosclerotic coronary artery disease; What is the relation? M Khosravani-Rudpishi, A Joharimoghadam, E Rayzan Journal of Cardiovascular and Thoracic Research 10 (4), 209, 2018 | 17 | 2018 |
| Introduction on coronavirus disease (COVID-19) pandemic: the global challenge N Rezaei, S Ashkevarian, MK Fathi, S Hanaei, Z Kolahchi, ... Coronavirus Disease-COVID-19, 1-22, 2021 | 15 | 2021 |
| Improving the function of neutrophils from chronic granulomatous disease patients using mesenchymal stem cells’ exosomes M Taghavi-Farahabadi, M Mahmoudi, SA Mahdaviani, K Baghaei, ... Human Immunology 81 (10-11), 614-624, 2020 | 15 | 2020 |
| Clinical and mutation description of the first iranian cohort of infantile inflammatory bowel disease: the iranian primary immunodeficiency registry (IPIDR) F Rahmani, E Rayzan, MR Rahmani, S Shahkarami, S Zoghi, A Rezaei, ... Immunological investigations 50 (4), 445-459, 2021 | 10 | 2021 |
| MicroRNAs and diabetes mellitus type 1 F Bahreini, E Rayzan, N Rezaei Current Diabetes Reviews 18 (2), 1-8, 2022 | 8 | 2022 |
| Neuroblastoma‐targeted nanoparticles and novel nanotechnology‐based treatment methods T Mobasheri, E Rayzan, M Shabani, M Hosseini, G Mahmoodi Chalbatani, ... Journal of Cellular Physiology, 2020 | 7 | 2020 |
| Reinforcing the primary immunotherapy modulators against acute leukemia; monoclonal antibodies in AML M Mahalleh, M Shabani, E Rayzan, N Rezaei Immunotherapy 11 (18), 1583-1600, 2019 | 7 | 2019 |
| Regional and national burden of leukemia and its attributable burden to risk factors in 21 countries and territories of North Africa and Middle East, 1990–2019: results from … M Heidari-Foroozan, S Saeedi Moghaddam, M Keykhaei, P Shobeiri, ... Journal of Cancer Research and Clinical Oncology 149 (8), 4149-4161, 2023 | 6 | 2023 |
| Novel G6PC3 mutations in patients with congenital neutropenia: case reports and review of the literature SF Maroufi, Z Shaka, H Mojtabavi, M Sadeghalvad, E Rayzan, I Sedighi, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | 6 | 2021 |
| Targeting Hypertension Screening in Low‐and Middle‐Income Countries: A Cross‐Sectional Analysis of 1.2 Million Adults in 56 Countries TK Kirschbaum, M Theilmann, N Sudharsanan, J Manne‐Goehler, ... Journal of the American Heart Association 10 (13), e021063, 2021 | 5 | 2021 |
| The clinical benefits of art therapy: definition, history, and outcomes with a focus on music therapy N Yazdanpanah, H Mojtabavi, H Ziaei, ZR Pirkoohi, E Rayzan, N Rezaei Multidisciplinarity and Interdisciplinarity in Health, 457-482, 2022 | 3 | 2022 |
| Novel BTK mutation in X-linked agammaglobulinemia: Report of a 17-year-old male Z Shaka, H Mojtabavi, E Rayzan, S Zoghi, S Shahkarami, JH Raul, ... Allergologia et immunopathologia 49 (2), 80-83, 2021 | 3 | 2021 |
| The efficacy of celecoxib during chemoradiation in locally advanced head and neck carcinoma; a phase 2 randomized placebo-controlled clinical trial M Aghili, R Ghalehtaki, E Rayzan, M Farzin, MM Mojahed, S Izadi, ... International Journal of Cancer Management 14 (5), 2021 | 3 | 2021 |
| A 3-year-old boy with an xp21 deletion syndrome: a case report S Sadeghmousavi, S Shahkarami, E Rayzan, S Ahmed, FH Gharalari, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2022 | 2 | 2022 |
| Coronary slow flow phenomenon and microalbuminuria: Is there any relationship A Amirzadegan, R Ghaderpanah, E Rayzan, A Aminorroaya, M Tajdini Turk Kardiyol Dernegi Arsivi Turk Kardiyol Derneginin Yayin Organidir 47 (8 …, 2019 | 2 | 2019 |
Nima RezaeiTehran University of Medical Sciences; Universal Scientific Education and Research Network (USERN)Verified email at tums.ac.ir
